Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Clinical trial NCT06134648 · COMPLETED

Trial details

NCT number: NCT06134648
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infection Healthy Volunteers Human Metapneumovirus

Start date: 2023-11-01
Primary completion: 2026-02-27
Enrollment: 646

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.